406 filings
Page 3 of 21
DEFA14A
tgy3vozb o53k2s
9 May 11
Additional proxy soliciting materials
12:00am
DEFA14A
utyjvtxhxfbx
9 May 11
Additional proxy soliciting materials
12:00am
425
2igr6z91k3rfzfch
9 May 11
Business combination disclosure
12:00am
8-K
htz46te26x
9 May 11
Important Additional Information and Where to Find It
12:00am
8-K
xhnpmwxv cl165kluo2
9 May 11
Entry into a Material Definitive Agreement
12:00am
425
z22afon9
9 May 11
Business combination disclosure
12:00am
425
t2eg9u qvmnl
9 May 11
Business combination disclosure
12:00am
8-K
vyoscej21 a8h
15 Apr 11
Bydureon™ Recommended for Approval In Europe
12:00am
8-K
wgfu4 od6p5my8txa
24 Mar 11
Departure of Directors or Certain Officers
12:00am
8-K
ls4dhv9e 0xfemdi
10 Mar 11
Exenatide Once Monthly Showed Positive Results In Phase 2 Study
12:00am
8-K
1kmtefb
3 Mar 11
DURATION-6 Top-Line Study Results Announced
12:00am
8-K
o53iocez589xii
3 Feb 11
Alkermes Reports Third Quarter Fiscal 2011 Financial Results
12:00am
8-K
9zm8q d61tmz3
27 Jan 11
Regulation FD Disclosure
12:00am
8-K
i6fvuw
18 Jan 11
Alkermes Elects Wendy L. Dixon, PH.D., to Board of Directors
12:00am
8-K
ah6e86z90za1925
4 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
komrazz7tx3b2j
20 Oct 10
Regulation FD Disclosure
12:00am
8-K
ab0kqgq
13 Oct 10
Regulation FD Disclosure
12:00am
8-K
g7atxwu6v65
5 Oct 10
Submission of Matters to a Vote of Security Holders
12:00am